| |
| |
|
| Insider
Information: |
Dorsey Brian |
| Relationship: |
Former SVP, Chief Dev ... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
203,317 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,181 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
203,317 |
|
|
| Total
Value |
$14,181 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Somaxon Pharmaceuticals, Inc. |
SOMX |
SVP, Technical Operati... |
2013-03-06 |
0 |
2007-04-25 |
0 |
Premium* |
|
|
Pernix Therapeutics Holdings |
PTX |
SVP Research |
2014-10-10 |
87,426 |
2013-04-19 |
0 |
Premium* |
|
|
Seelos Therapeutics Inc |
SEEL |
Former SVP, Chief Dev ... |
2018-08-30 |
115,891 |
2014-12-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SEEL |
Seelos Therapeutics Inc |
Former SVP, Chief Dev Officer |
– – – |
2018-08-30 |
4 |
D |
$0.33 |
$14,264 |
D/D |
(43,225) |
115,891 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Former SVP, Chief Dev Officer |
– – – |
2018-08-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
81,775 |
159,116 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
SVP, Chief Development Officer |
• – – |
2018-01-01 |
4 |
D |
$1.84 |
$10,092 |
D/D |
(5,485) |
159,116 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
SVP, Chief Development Officer |
• – – |
2017-09-05 |
4 |
D |
$1.56 |
$21,985 |
D/D |
(14,093) |
164,601 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
SVP, Chief Development Officer |
• – – |
2017-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
178,694 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
SVP, Chief Development Officer |
• – – |
2017-02-15 |
4 |
D |
$2.78 |
$4,156 |
D/D |
(1,495) |
103,694 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
SVP, Chief Development Officer |
• – – |
2017-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
105,189 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
SVP, Chief Development Officer |
• – – |
2016-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
301,891 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
SVP, Chief Development Officer |
• – – |
2016-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
301,891 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
SVP, Chief Development Officer |
• – – |
2016-04-25 |
4/A |
A |
$0.00 |
$0 |
D/D |
0 |
51,891 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
SVP, Chief Development Officer |
• – – |
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
41,891 |
51,891 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Chief Development Officer |
• – – |
2014-12-29 |
4 |
B |
$1.05 |
$10,481 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
SVP Research |
• • – |
2014-10-10 |
4 |
A |
$0.00 |
$0 |
D/D |
83,333 |
87,426 |
0 |
- |
|
| PTX |
Pernix Therapeutics Holdi... |
SVP, ResearchOfficer |
• – – |
2013-04-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,538 |
|
- |
|
| PTX |
Pernix Therapeutics Holdi... |
SVP, ResearchOfficer |
• – – |
2013-04-19 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
13,538 |
|
- |
|
| PTX |
Pernix Therapeutics Holdi... |
SVP, Research |
• • – |
2013-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
97,654 |
111,192 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
• • – |
2013-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(28,340) |
0 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
• – – |
2012-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,494 |
52,264 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
• – – |
2012-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
50,770 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
• – – |
2012-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
15,716 |
166,160 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
• – – |
2012-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
15,992 |
150,444 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
• – – |
2012-01-03 |
4 |
AS |
$0.48 |
$4,289 |
D/D |
(9,000) |
134,452 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
• – – |
2011-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
123,452 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
• – – |
2010-12-01 |
4 |
AS |
$2.68 |
$22,727 |
D/D |
(8,468) |
43,452 |
0 |
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
SVP, Technical Operations |
• – – |
2010-09-01 |
4 |
AS |
$4.27 |
$12,810 |
D/D |
(3,000) |
51,920 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
